← All companies

AVBP

ArriVent BioPharma, Inc.

AVBP Nasdaq Pharmaceutical Preparations EDGAR ↗

$29.64

-1.02 -3.33%

Key statistics

from XBRL data in SEC filings

Market cap

$1.38B

Revenue (TTM)

—

Net income (TTM)

-$145M

EPS (TTM)

$-3.38

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

$62.1M

Total assets

$349M

Gross margin

—

52-week range

$16.10 – $35.83

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Jun 22, 2026 8-K Other events May 11, 2026 10-Q Quarter ended 2026-03-31 May 11, 2026 8-K Results of operations (earnings release) May 11, 2026 8-K Regulation FD disclosure; Other events Mar 17, 2026 10-K Fiscal year ended 2025-12-31 Mar 5, 2026 8-K Results of operations (earnings release) Mar 5, 2026 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Results of operations (earnings release) Nov 10, 2025 8-K Regulation FD disclosure; Other events Sep 9, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Results of operations (earnings release) Aug 11, 2025 8-K Other events Jul 21, 2025 8-K Entered a material agreement; Other events Jul 2, 2025 8-K Regulation FD disclosure; Other events Jun 23, 2025 8-K Shareholder vote results Jun 20, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Results of operations (earnings release) May 12, 2025 8-K Director or officer change; Regulation FD disclosure Apr 28, 2025 8-K Changed accountants Mar 13, 2025 8-K Results of operations (earnings release) Mar 3, 2025 10-K Fiscal year ended 2024-12-31 Mar 3, 2025 8-K Entered a material agreement; Regulation FD disclosure Jan 22, 2025 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Results of operations (earnings release) Nov 14, 2024 8-K Regulation FD disclosure; Other events Sep 9, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Results of operations (earnings release) Aug 14, 2024 8-K/A Director or officer change Jul 9, 2024 8-K/A Director or officer change Jul 9, 2024 8-K Entered a material agreement; Regulation FD disclosure Jun 5, 2024 8-K Director or officer change May 16, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Results of operations (earnings release) May 8, 2024 8-K Director or officer change Apr 22, 2024 10-K Fiscal year ended 2023-12-31 Mar 28, 2024 8-K Results of operations (earnings release) Mar 28, 2024 8-K Amended charter or bylaws; Other events Jan 30, 2024

Other filings

SCHEDULE 13G/A Jul 27, 2026 4 OWNERSHIP DOCUMENT Jun 22, 2026